Supply High Quality Tesamorelin Powder Peptide, Shenzhen, Guangdong

Tesamorelin peptide is a synthetic analog of growth hormone releasing hormone. Tesamorelin injection is a hormone similar to that released by the hypothalamus and is primarily used to treat abdominal and stomach fat caused by human immunodeficiency virus infection. Tesamorelin peptide was first approved by the FDA in 2010 and is marketed under the trade name Egrifta SV. Studies have shown that Tesamorelin can reduce visceral fat in patients by 20%. 

Benefits Of Tesamorelin
 

Tesamorelin works by increasing growth hormone levels, causing fat stored in the body to break down into fatty acids, thereby converting them into fuel for body energy. Tesamorelin burns fat around abdominal organs but not subcutaneous fat tissue.

Stimulate growth hormone secretion

Growth hormone decreases with age. By stimulating the secretion and release of growth hormone from the pituitary gland, Tesamorelin can restore growth hormone levels to normal levels.

Improve cognitive abilities

Studies have shown that Tesamorelin can restore growth hormone to normal levels, which is beneficial to improving mental ability, thereby helping the elderly and people with mild cognitive impairment improve concentration and memory.

Restore peripheral nerve loss

Peripheral nerve damage caused by surgery, diabetes and other diseases can lead to loss of movement and sensory abilities. Tesamorelin can improve nerve regeneration, showing its potential role as a treatment for peripheral nerve loss.

Gain muscle

Tesamorelin restores muscle strength in patients with growth hormone deficiency. As a GHRH analog, Tesamorelin increases and normalizes lean muscle mass.

Tesamorelin powder is the active ingredient of Tesamorein injection or Tesamorelin-based pharmaceutical drugs. Tesamorelin is FDA-a